176 related articles for article (PubMed ID: 29716667)
1. Can Flanders resist the measles outbreak? Assessing vaccination coverage in different age groups among Flemish residents.
Braeckman T; Theeten H; Roelants M; Blaizot S; Hoppenbrouwers K; Maertens K; Van Damme P; Vandermeulen C
Epidemiol Infect; 2018 Jun; 146(8):1043-1047. PubMed ID: 29716667
[TBL] [Abstract][Full Text] [Related]
2. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
[TBL] [Abstract][Full Text] [Related]
3. Vaccination coverage and sociodemographic determinants of measles-mumps-rubella vaccination in three different age groups.
Vandermeulen C; Roelants M; Theeten H; Van Damme P; Hoppenbrouwers K
Eur J Pediatr; 2008 Oct; 167(10):1161-8. PubMed ID: 18204860
[TBL] [Abstract][Full Text] [Related]
4. Measles, mumps, rubella prevention: how can we do better?
Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
[TBL] [Abstract][Full Text] [Related]
5. Vaccination coverage in 14-year-old adolescents: documentation, timeliness, and sociodemographic determinants.
Vandermeulen C; Roelants M; Theeten H; Depoorter AM; Van Damme P; Hoppenbrouwers K
Pediatrics; 2008 Mar; 121(3):e428-34. PubMed ID: 18310163
[TBL] [Abstract][Full Text] [Related]
6. Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium.
Theeten H; Vandermeulen C; Roelants M; Hoppenbrouwers K; Depoorter AM; Van Damme P
Acta Paediatr; 2009 Aug; 98(8):1307-12. PubMed ID: 19432835
[TBL] [Abstract][Full Text] [Related]
7. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
[TBL] [Abstract][Full Text] [Related]
8. Measles outbreak linked to insufficient vaccination coverage in Nouvelle-Aquitaine Region, France, October 2017 to July 2018.
Bernadou A; Astrugue C; Méchain M; Le Galliard V; Verdun-Esquer C; Dupuy F; Dina J; Aït-Belghiti F; Antona D; Vandentorren S
Euro Surveill; 2018 Jul; 23(30):. PubMed ID: 30064543
[TBL] [Abstract][Full Text] [Related]
9. A novel measles outbreak control strategy in the Netherlands in 2013-2014 using a national electronic immunization register: A study of early MMR uptake and its determinants.
Nic Lochlainn LM; Woudenberg T; van Lier A; Zonnenberg I; Philippi M; de Melker HE; Hahné SJM
Vaccine; 2017 Oct; 35(43):5828-5834. PubMed ID: 28923422
[TBL] [Abstract][Full Text] [Related]
10. Tolerability of Early Measles-Mumps-Rubella Vaccination in Infants Aged 6-14 Months During a Measles Outbreak in The Netherlands in 2013-2014.
van der Maas NA; Woudenberg T; Hahné SJ; de Melker HE
J Infect Dis; 2016 May; 213(9):1466-71. PubMed ID: 26690343
[TBL] [Abstract][Full Text] [Related]
11. Vaccines for measles, mumps and rubella in children.
Demicheli V; Rivetti A; Debalini MG; Di Pietrantonj C
Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD004407. PubMed ID: 22336803
[TBL] [Abstract][Full Text] [Related]
12. Measles outbreak associated with a preschool setting among partially vaccinated children in the Tel Aviv District, Israel, October 2023.
Sheffer R; Bucris E; Amitai Z; Indenbaum V; Lustig Y; Savion M; Nuss N; Roee Singer S; Alroy Preis S; Almagor S; Leshem E; Salama M
Vaccine; 2024 May; 42(13):3153-3156. PubMed ID: 38627149
[TBL] [Abstract][Full Text] [Related]
13. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
Newtonraj A; Vincent A; Selvaraj K; Manikandan M
Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
[TBL] [Abstract][Full Text] [Related]
14. Specialist vaccination advice and pockets of resistance to MMR vaccination: lessons from an outbreak of measles.
Morgan OW; Meltzer M; Muir D; Hogan H; Seng C; Hill J; Beckford J
Commun Dis Public Health; 2003 Dec; 6(4):330-3. PubMed ID: 15067861
[TBL] [Abstract][Full Text] [Related]
15. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
Alfredsson R; Svensson E; Trollfors B; Borres MP
Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890
[TBL] [Abstract][Full Text] [Related]
16. Successes and challenges for preventing measles, mumps and rubella by vaccination.
Bankamp B; Hickman C; Icenogle JP; Rota PA
Curr Opin Virol; 2019 Feb; 34():110-116. PubMed ID: 30852425
[TBL] [Abstract][Full Text] [Related]
17. Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013.
Hens N; Abrams S; Santermans E; Theeten H; Goeyvaerts N; Lernout T; Leuridan E; Van Kerckhove K; Goossens H; Van Damme P; Beutels P
Euro Surveill; 2015 Jan; 20(1):. PubMed ID: 25613653
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey.
Amela C; Pachón I; de Ory F
Eur J Epidemiol; 2003; 18(1):71-9. PubMed ID: 12705626
[TBL] [Abstract][Full Text] [Related]
19. Suboptimal MMR2 vaccine coverage in six counties in Norway detected through the national immunisation registry, April 2014 to April 2017.
Hagerup-Jenssen M; Kongsrud S; Riise ØR
Euro Surveill; 2017 Apr; 22(17):. PubMed ID: 28489000
[TBL] [Abstract][Full Text] [Related]
20. Increasing childhood vaccination coverage of the refugee and migrant population in Greece through the European programme PHILOS, April 2017 to April 2018.
Mellou K; Silvestros C; Saranti-Papasaranti E; Koustenis A; Pavlopoulou ID; Georgakopoulou T; Botsi C; Terzidis A
Euro Surveill; 2019 Jul; 24(27):. PubMed ID: 31290391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
